Achieve Life Sciences, Inc. (ACHV) stock
ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as QUIT
$6.61+0.23 (+3.53%)
Close on Oct 19, 2026Market cap $679.67MP/E –Yield –
Achieve Life Sciences gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for Achieve Life Sciences
Achieve Life Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?